CORC

在结果中检索

CORC

浏览/检索结果: 共53条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
CHARMM-GUI DEER facilitator for spin-pair distance distribution calculations and preparation of restrained-ensemble molecular dynamics simulations 期刊论文
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2019, 页码: 6
作者:  Qi, Yifei;  Lee, Jumin;  Cheng, Xi;  Shen, Rong;  Islam, Shahidul M.
收藏  |  浏览/下载：15/0  |  提交时间：2020/07/01
Gene expression imputation across multiple brain regions provides insights into schizophrenia risk 期刊论文
NATURE GENETICS, 2019, 卷号: 51, 期号: 4, 页码: 659-+
作者:  Huckins, Laura M.;  Dobbyn, Amanda;  Ruderfer, Douglas M.;  Hoffman, Gabriel;  Wang, Weiqing
收藏  |  浏览/下载：151/0  |  提交时间：2019/04/22
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer 期刊论文
2019, 卷号: 30, 期号: 4, 页码: 558-566
作者:  Robson, M. E.;  Tung, N.;  Conte, P.;  Im, S-A;  Senkus, E.
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe;  Masuda, Norikazu
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
EUROPEAN JOURNAL OF CANCER, 2018-04-01
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
2018, 卷号: 92, 页码: S19-S20
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Domchek, Susan M.;  Robson, Mark;  Im, Seock-Ah;  Senkus, Elzbieta;  Xu, Binghe
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace